Judge criticises Allergan’s Native American tribe deal, invalidates Restasis patents
Judge Bryson in the Eastern District of Texas has noted “serious concerns” about Allergan transferring patents to the Saint Regis Mohawk Tribe to benefit from sovereign immunity but joined the tribe to litigation against Mylan and Teva – “Allergan’s tactic, if successful, could spell the end of the PTO’s IPR program”
Allergan’s controversial effort to avoid its patents for dry eye treatment Restasis being invalidated at the Patent Trial and Appeal Board (PTAB) by transferring them to a Native American tribe has taken a surprising turn – the judge in its...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.